CollPlant Biotechnologies (CLGN) Gross Margin (2017 - 2026)
CollPlant Biotechnologies (CLGN) recorded Gross Margin of -422.22% in the quarter ended Jun 30, 2026, down 418.31 percentage points from -3.91% a year earlier and down 89.35 percentage points from the prior quarter.
CollPlant Biotechnologies (CLGN) Gross Margin (2017 - 2026) Analysis & Trends
On a TTM basis, CollPlant Biotechnologies' Gross Margin came in at -321.70% as of Jun 30, 2026, down 383.48 percentage points year-over-year; for the year ended Dec 31, 2025, it came in at 64.78%, up 280.32 percentage points from the prior year.
- Annual Gross Margin has a five-year change of +13.70 percentage points (years ended Dec 2020 to Dec 2025).
- Across earlier years, Gross Margin came in at -215.53% in the year ended Dec 31, 2024 (-297.37 pp), 81.83% in the year ended Dec 31, 2023 (+115.61 pp), -33.78% in the year ended Dec 31, 2022 (-120.96 pp) and 87.18% in the year ended Dec 31, 2021 (+36.10 pp).
- The figure for the quarter ended Jun 30, 2026 is the lowest quarterly Gross Margin since the quarter ended Sep 30, 2024.
- On a year-over-year basis, Gross Margin has declined for three consecutive quarters, with an average year-over-year change of +6.50 percentage points over the last eight quarters.
- Peak year-over-year performance for Gross Margin in the last five years was a gain of 6450.65 percentage points in the quarter ended Sep 30, 2025, against a drop of 6153.49 percentage points in the quarter ended Sep 30, 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at -332.88% (quarter ended Mar 30, 2026), -220.00% (quarter ended Dec 31, 2025) and -249.35% (quarter ended Sep 30, 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 85.78% |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 68.19% |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 74.74% |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 73.54% |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 78.02% |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 83.60% |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 72.04% |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 79.76% |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 72.78% |
| 10 | CollPlant Biotechnologies | 4.68 Mn | -17.68 Mn | -456,000.00 | -422.22% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -422.22% |
| Dec 31, 2025 | -220.00% |
| Sep 30, 2025 | -249.35% |
| Jun 30, 2025 | -3.91% |
| Mar 31, 2025 | 90.85% |
| Dec 31, 2024 | -65.85% |
| Sep 30, 2024 | -6,700.00% |
| Jun 30, 2024 | -115.26% |
| Mar 31, 2024 | -456.12% |
| Dec 31, 2023 | -158.53% |
| Sep 30, 2023 | -546.51% |
| Jun 30, 2023 | 93.96% |
| Mar 31, 2023 | 24.94% |
| Dec 31, 2022 | -6.90% |
| Sep 30, 2022 | -142.20% |
| Jun 30, 2022 | 34.85% |
| Dec 31, 2021 | -76.77% |
| Sep 30, 2021 | -1.43% |
| Jun 30, 2021 | 37.92% |
| Mar 31, 2021 | 93.89% |
CollPlant Biotechnologies Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=CLGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "CLGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=CLGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();